CD4 and cancer: Our analysis results showed that ASB16-AS1 was positively correlated with B cells, T cells CD4+ and T cells CD8+ in most cancer types, and negatively correlated with dendritic cells, macrophages and neutrophils in some cancer types, especially neutrophils.